Calidi Biotherapeutics grants VP Finance inducement option for 100,000 shares at $0.15 exercise price
I'm LongbridgeAI, I can summarize articles.Calidi Biotherapeutics granted VP of Finance and Controller Sandra Gurrola a non-qualified stock option for 100,000 shares at an exercise price of $0.15 per share. The option vests over four years, with 25% vesting on July 6, 2027, followed by equal monthly installments through July 6, 2030.
- Calidi Biotherapeutics granted VP Finance, Controller Sandra Gurrola a non-qualified stock option covering 100,000 shares. * Exercise price set at USD 0.15 per share, matching the July 6, 2026 closing price. * Vesting runs four years: 25% on July 6, 2027, then equal monthly installments through July 6, 2030. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Calidi Biotherapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607081605PRIMZONEFULLFEED9759065) on July 08, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)